Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Adam Eckert

Why Quotient Stock Is Soaring Today

Quotient Ltd (NASDAQ:QTNT) shares are trading higher Wednesday after the company issued guidance above analyst estimates.

Quotient announced that it has rescheduled its financial results to June 24. The company provided a preview of its results in accordance with the rescheduling. 

Quotient said it expects product sales from its reagent business to be $9.8 million in the fourth quarter and $38.5 million for the full year. Average analyst estimates expect the company to report revenue of $8.17 million in the fourth quarter, according to data from Benzinga Pro.

Quotient is a commercial-stage diagnostics company that is involved in the development, manufacturing and commercialization of conventional reagent products used for blood grouping within the global transfusion diagnostics market.

See Also: Why Athira Pharma Stock Is Plunging

QTNT Price Action: Quotient has traded between $4.40 and 27 cents over a 52-week period.

The stock was up 31.1% at 49 cents at time of publication.

Photo: fernando zhiminaicela from Pixabay.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.